LIST OF TABLES
TABLE 01.CLINICAL TRIALS - COPD AND ASTHMA DEVICES
TABLE 02.COPD AND ASTHMA DEVICES PATENTS
TABLE 03.ADVANTAGES AND DISADVANTAGES OF MARKETED PORTABLE INHALER DEVICES
TABLE 04.PERCENTAGE OF SMOKER POPULATION BY RACE/ETHNICITY, 2016
TABLE 05.COST OF ASTHMA IN BILLION, 2015
TABLE 06.COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 07.RESCUE INHALERS VS MAINTENANCE INHALERS
TABLE 08.COMMON TYPES OF INHALERS
TABLE 09.TOP 10 COPD INHALERS
TABLE 10.INHALERS COPD AND ASTHMA DEVICES MARKET, BY REGION 2019-2027, ($MILLION)
TABLE 11.DRY POWDER INHALERS
TABLE 12.TYPES OF METERED DOSE INHALERS (MDIS)
TABLE 13.COMMERCIALIZED NEBULIZERS AND ITS COST
TABLE 14.NEBULIZERS COPD AND ASTHMA DEVICES MARKET, BY REGION 2019-2027, ($MILLION)
TABLE 15.COPD AND ASTHMA DEVICES MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 16.ASTHMA COPD ANDS ASTHMA DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 17.COPD AND ASTHMA DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 18.COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 19.RETAIL PHARMACIES COPD AND ASTHMA DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 20.HOSPITALS COPD AND ASTHMA DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 21.ONLINE PHARMACIES COPD AND ASTHMA DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 22.GLOBAL COPD AND ASTHMA DEVICES MARKET, BY REGION 2019-2027 ($MILLION)
TABLE 23.NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 24.NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 25.NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 26.NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 27.U.S. COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 28.U.S. COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 29.U.S. COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 30.CANADA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 31.CANADA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 32.CANADA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 33.MEXICO COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 34.MEXICO COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 35.MEXICO COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 36.EUROPE COPD AND ASTHMA DEVICESMARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 37.EUROPE COPD AND ASTHMA DEVICESMARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 38.EUROPE COPD AND ASTHMA DEVICESMARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 39.GERMANY COPD AND ASTHMA DEVICESMARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 40.GERMANY COPD AND ASTHMA DEVICESMARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 41.GERMANY COPD AND ASTHMA DEVICESMARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 42.UK COPD AND ASTHMA DEVICESMARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 43.UK COPD AND ASTHMA DEVICESMARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 44.UK COPD AND ASTHMA DEVICESMARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 45.FRANCE COPD AND ASTHMA DEVICESMARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 46.FRANCE COPD AND ASTHMA DEVICESMARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 47.FRANCE COPD AND ASTHMA DEVICESMARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 48.ITALY COPD AND ASTHMA DEVICESMARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 49.ITALY COPD AND ASTHMA DEVICESMARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 50.ITALY COPD AND ASTHMA DEVICESMARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 51.RUSSIA COPD AND ASTHMA DEVICESMARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 52.RUSSIA COPD AND ASTHMA DEVICESMARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 53.RUSSIA COPD AND ASTHMA DEVICESMARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 54.REST OF EUROPE COPD AND ASTHMA DEVICESMARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 55.REST OF EUROPE COPD AND ASTHMA DEVICESMARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 56.REST OF EUROPE COPD AND ASTHMA DEVICESMARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 57.ASIA-PACIFIC COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 58.ASIA-PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 59.ASIA-PACIFIC COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 60.ASIA-PACIFIC COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 61.JAPAN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 62.JAPAN COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 63.JAPAN COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 64.CHINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 65.CHINA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 66.CHINA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 67.INDIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 68.INDIA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 69.INDIA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 70.AUSTRALIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 71.AUSTRALIA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 72.AUSTRALIA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 76.LAMEA COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 77.LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 78.LAMEA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 79.LAMEA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 80.BRAZIL COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 81.BRAZIL COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 82.BRAZIL COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 83.ARGENTINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 84.ARGENTINA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 85.ARGENTINA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 86.SAUDI ARABIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 87.SAUDI ARABIA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 88.SAUDI ARABIA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 89.COLOMBIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 90.COLOMBIA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 91.COLOMBIA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 92.TURKEY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 93.TURKEY COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 94.TURKEY COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 95.REST OF LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 96.REST OF LAMEA COPD AND ASTHMA DEVICES MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 97.REST OF LAMEA COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 98.AEROGEN: COMPANY SNAPSHOT
TABLE 99.AEROGEN: PRODUCT PORTFOLIO
TABLE 100.ASTRAZENECA: COMPANY SNAPSHOT
TABLE 101.ASTRAZENECA: OPERATING SEGMENTS
TABLE 102.ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 01.BAXTER: COMPANY SNAPSHOT
TABLE 02.BAXTER: BUSINESS UNITS
TABLE 03.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 04.BOEHRINGER INGELHEIM: PRODUCT BUSINESS SEGMENTS
TABLE 05.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 06.3M: COMPANY SNAPSHOT
TABLE 07.3M: OPERATING BUSINESS SEGMENTS
TABLE 08.3M: PRODUCT PORTFOLIO
TABLE 09.GF HEALTH PRODUCTS: SNAPSHOT
TABLE 10.GF HEALTH PRODUCTS: PRODUCT PORTFOLIO
TABLE 11.GSK.: COMPANY SNAPSHOT
TABLE 12.GSK: OPERATING SEGMENTS
TABLE 13.GSK: PRODUCT PORTFOLIO
TABLE 14.PHILIPS: COMPANY SNAPSHOT
TABLE 15.PHILIPS: OPERATING SEGMENTS
TABLE 16.PHILIPS: PRODUCT PORTFOLIO
TABLE 17.NOVARTIS: COMPANY SNAPSHOT
TABLE 18.NOVARTIS: OPERATING SEGMENTS
TABLE 19.NOVARTIS: PRODUCT PORTFOLIO
TABLE 20.PARI: COMPANY SNAPSHOT
TABLE 21.PARI: PRODUCT PORTFOLIO
TABLE 22.PARI: PRODUCT PORTFOLIO
TABLE 23.SMITHS MEDICAL: COMPANY SNAPSHOT
TABLE 24.SMITHS MEDICAL: OPERATING SEGMENTS
TABLE 25.SMITHS MEDICAL: PRODUCT PORTFOLIOG
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01.TOP FACTORS IMPACTING GLOBAL COPD AND ASTHMA DEVICES MARKET, 2015-2022
FIGURE 02.TOP INVESTMENT POCKETS OF GLOBAL COPD AND ASTHMA DEVICES MARKET, BY COUNTRY
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2018*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2018* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2018* (%)
FIGURE 06.VALUE CHAIN ANALYSIS OF GLOBAL COPD AND ASTHMA DEVICES
FIGURE 07.PATENT REGISTRATIONS BY REGION 2011-2014 (%)
FIGURE 08.U.S. PATENT REGISTRATIONS, BY PRODUCT, 2011-2014 (%)
FIGURE 09.EUROPE PATENT REGISTRATIONS, BY PRODUCT 2011-2014 (%)
FIGURE 10.JAPAN PATENT REGISTRATIONS, BY PRODUCT, 2012-2014 (%)
FIGURE 11.THE FOLLOWING FIGURE DEPICTS THE PREVALENCE OF COPD AMONG PEOPLE AGED 45 AND ABOVE, BY AGE AND SEX (2017-2018).
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF INHALERS ASTHMA COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NEBULIZERS ASTHMA COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ASTHMA COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF RETAIL PHARMACIES COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOPSPITALS COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE PAYERS COPD AND ASTHMA DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 19.ASTRAZENECA: NET SALES, 2016-2018 ($THOUSAND)
FIGURE 20.ASTRAZENECA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21.ASTRAZENECA: REVENUE SHARE BY REGION 2018 (%)
FIGURE 22.NET SALES, 2016-2018 ($MILLION)
FIGURE 23.BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2018 (%)
FIGURE 24.BAXTER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25.BOEHRINGER INGELHEIM: NET SALES, 2016-2018 ($MILLION)
FIGURE 26.BOEHRINGER INGELHEIM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27.BOEHRINGER INGELHEIM: REVENUE SHARE BY REGION, 2018(%)
FIGURE 28.3M: NET SALES, 2016-2018 ($MILLION)
FIGURE 29.3M: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30.3M: REVENUE SHARE BY REGION, 2018(%)
FIGURE 31.GSK: REVENUE, 2016-2018($MILLION)
FIGURE 32.GSK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33.GSK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34.PHILIPS: NET SALES, 2016-2018 ($MILLION)
FIGURE 35.PHILIPS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36.PHILIPS: REVENUE SHARE BY REGION, 2018(%)
FIGURE 37.NOVARTIS: NET SALES, 2016-2018 ($MILLION)
FIGURE 38.NOVARTIS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39.NOVARTIS: REVENUE SHARE BY REGION 2018(%)
FIGURE 40.SMITHS MEDICAL: NET SALES, 2016-2018 ($MILLION)
FIGURE 41.SMITHS MEDICAL: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 42.SMITHS MEDICAL: REVENUE SHARE BY REGION, 2018 (%)
